CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to create a new treatment method for hepatocellular carcinoma (HCC) using microencapsulated stem cells to deliver specific therapeutic proteins directly to tumors. This approach seeks to enhance drug delivery while minimizing systemic side effects, potentially improving patient outcomes in HCC manageme…
In this multidisciplinary research proposal we aim to develop a new therapeutic platform for hepatocellular carcinoma (HCC). HCC is the third leading cause of cancer death worldwide with a death rate greater than 600,000 persons annually.
Currently the main curative treatments include resection, liver transplantation, or percutaneous local ablative treatment.
However, all these approaches are primarily suitable for asymptomatic patients with very early and early HCCs.
Transarterial chemoemboliza…
BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
